<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03706313</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00100879</org_study_id>
    <nct_id>NCT03706313</nct_id>
  </id_info>
  <brief_title>Genicular Nerve Block for Total Knee Arthroplasty</brief_title>
  <official_title>A Comparison of Analgesic Efficacy of Ultrasound-guided Genicular Nerve Block Versus Saline Injection for Total Knee Replacement: a Prospective, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to examine the analgesic efficacy of genicular nerve blocks for pain after&#xD;
      total knee replacement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Part of the way in which pain is controlled during total knee replacement surgery is through&#xD;
      a nerve block. The investigators have developed an effective protocol for pain control after&#xD;
      knee replacement, but know that many patients still experience pain around the knee after&#xD;
      knee replacement. There are nerves around the knee that carry pain impulses from behind the&#xD;
      knee. The investigators believe that placing numbing medicine around these nerves can help&#xD;
      with pain in front of the knee after surgery, in addition to the standard nerve block placed&#xD;
      for knee replacement surgery. This may result in taking less pain medication by mouth,and&#xD;
      having less pain with movement. For this study, before the operation, either a placebo&#xD;
      solution or the local anesthetic bupivacaine (a numbing solution) will be placed at three&#xD;
      sites around the knee where these nerves reside. The investigators will evaluate how&#xD;
      participants feel in recovery after surgery, during the stay in the hospital, and call at&#xD;
      home one week after surgery. Knowing if numbing these nerves helps with pain after surgery&#xD;
      will help us further refine our postoperative care plan for patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Actual">October 22, 2019</completion_date>
  <primary_completion_date type="Actual">October 16, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption at 24 Hours Post-op</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>Opioid consumption documented in medical recorded will be converted to oral morphine equivalents.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Worst Pain Rating Score (NRS-11) at Rest on Postoperative Day 1</measure>
    <time_frame>Postoperative Day 1</time_frame>
    <description>The Numerical Rating Scale (NRS) is an 11-point numeric rating scale, with 0 representing &quot;no pain&quot; and 10 &quot;unbearable pain.&quot; This scale demonstrates reliability and validity and is widely used to assess acute pain after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worst Pain Rating Score (NRS-11) With Movement on Postoperative Day 1</measure>
    <time_frame>Postoperative day 1</time_frame>
    <description>The Numerical Rating Scale (NRS) is an 11-point numeric rating scale, with 0 representing &quot;no pain&quot; and 10 &quot;unbearable pain.&quot; This scale demonstrates reliability and validity and is widely used to assess acute pain after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Opioid Consumption Through 48 Hours</measure>
    <time_frame>48 hours</time_frame>
    <description>Total of all opioids consumed converted to oral morphine equivalents.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption on Postoperative Day 7</measure>
    <time_frame>Postoperative day 7</time_frame>
    <description>Self-reported (by telephone questionnaire) opioid consumption in oral morphine equivalents on postoperative day 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worst Pain Rating Score (NRS-11) on Postoperative Day 7</measure>
    <time_frame>Postoperative day 7</time_frame>
    <description>The Numerical Rating Scale (NRS) is an 11-point numeric rating scale, with 0 representing &quot;no pain&quot; and 10 &quot;unbearable pain.&quot; This scale demonstrates reliability and validity and is widely used to assess acute pain after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality Measured by Number of Times Awakened by Pain During the First Postoperative Night</measure>
    <time_frame>Postoperative day 1</time_frame>
    <description>The patient will be questioned by a member of the research team about how many times they were awoken by pain overnight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction With Pain Control at 24 h</measure>
    <time_frame>24 hours</time_frame>
    <description>Patient reported satisfaction with his/her pain control at 24 h on a scale of 0-10 (0=completely dissatisfied, 10=completely satisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction With Pain Control on Postoperative Day 7</measure>
    <time_frame>Postoperative day 7</time_frame>
    <description>Patient reported satisfaction with his/her pain control on postoperative day 7 on a scale of 0-10 (0=completely dissatisfied, 10=completely satisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>20 Meter Walk Test Time Performed on Postoperative Day 1</measure>
    <time_frame>On postoperative day 1</time_frame>
    <description>This standardized test measures the time it takes for the participant to walk 20 meters at their usual walking pace. The 20-meter walk test is a physical function measure commonly used in clinical research studies and rehabilitation clinics to measure gait speed and monitor changes in patients' physical function over time.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Post-operative Pain</condition>
  <arm_group>
    <arm_group_label>Genicular nerve block with bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. Color Doppler will be used to identify the arterial structures which serve as landmarks for the corresponding nerves.&#xD;
After skin local anesthetic infiltration, a 10 cm 21G insulated block needle will be inserted and aligned with the ultrasound scanning plane. Once satisfactory position of the needle is confirmed, 5mL of a solution containing 15 ml 0.25% bupivacaine with 2mg dexamethasone or 5mL saline will be slowly injected. Spread of local anesthetic will be documented adjacent to the target nerve. This procedure will be performed at the site of the three genicular nerves described.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Genicular nerve block with saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. Color Doppler will be used to identify the arterial structures which serve as landmarks for the corresponding nerves.&#xD;
After skin local anesthetic infiltration, a 10 cm 21G insulated block needle will be inserted and aligned with the ultrasound scanning plane (in-plane approach). Once satisfactory position of the needle time is confirmed, 5mL of a saline will be slowly injected. Spread of local anesthetic will be documented adjacent to the target nerve. This procedure will be performed at the site of the three genicular nerves described.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>15mL 0.25% bupivacaine</intervention_name>
    <description>Patients will be randomly assigned to either a genicular nerve block with bupivacaine or saline</description>
    <arm_group_label>Genicular nerve block with bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Genicular nerve block</intervention_name>
    <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. Color Doppler will be used to identify the arterial structures which serve as landmarks for the corresponding nerves.&#xD;
After skin local anesthetic infiltration, a 10 cm 21G insulated block needle will be inserted and aligned with the ultrasound scanning plane. Once satisfactory position of the needle is confirmed, 5mL of a solution containing 15 ml of 0.25% bupivacaine with 2mg dexamethasone or 5mL saline will be slowly injected. Spread of local anesthetic will be documented adjacent to the target nerve. This procedure will be performed at the site of the three genicular nerves described.</description>
    <arm_group_label>Genicular nerve block with bupivacaine</arm_group_label>
    <arm_group_label>Genicular nerve block with saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Patients will be randomly assigned to either a genicular nerve block with bupivacaine or saline</description>
    <arm_group_label>Genicular nerve block with saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects scheduled for primary elective total knee arthroplasty&#xD;
&#xD;
          -  American Society of Anesthesiologists Physical Status I-III&#xD;
&#xD;
          -  BMI 18-40 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to cooperate with protocol&#xD;
&#xD;
          -  Inability to understand or speak English&#xD;
&#xD;
          -  Allergy to ropivacaine, bupivacaine or other local anesthetic&#xD;
&#xD;
          -  Contraindication to peripheral nerve block (e.g. local infection, neurologic deficit&#xD;
             or disorder, previous trauma or surgery to ipsilateral knee, etc.)&#xD;
&#xD;
          -  Revision knee surgery&#xD;
&#xD;
          -  Chronic opioid consumption (daily morphine equivalent of &gt;30 mg for at least four&#xD;
             weeks prior to surgery)&#xD;
&#xD;
          -  History of chronic pain&#xD;
&#xD;
          -  History of psychiatric disorder&#xD;
&#xD;
          -  History of diabetes mellitus&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Gadsden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Hospital</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 11, 2018</study_first_submitted>
  <study_first_submitted_qc>October 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2018</study_first_posted>
  <results_first_submitted>October 14, 2020</results_first_submitted>
  <results_first_submitted_qc>October 14, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 5, 2020</results_first_posted>
  <last_update_submitted>March 5, 2021</last_update_submitted>
  <last_update_submitted_qc>March 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Total knee replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 3, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/13/NCT03706313/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
          <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
        </group>
        <group group_id="P2">
          <title>Genicular Nerve Block With Saline</title>
          <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
          <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
        </group>
        <group group_id="B2">
          <title>Genicular Nerve Block With Saline</title>
          <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.9" spread="6.8"/>
                    <measurement group_id="B2" value="67.1" spread="7.6"/>
                    <measurement group_id="B3" value="68.9" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="171.1" spread="10.0"/>
                    <measurement group_id="B2" value="170.4" spread="11.3"/>
                    <measurement group_id="B3" value="170.7" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86.5" spread="19.8"/>
                    <measurement group_id="B2" value="87.2" spread="17.5"/>
                    <measurement group_id="B3" value="86.8" spread="18.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/mâˆ§2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.3" spread="4.7"/>
                    <measurement group_id="B2" value="30.0" spread="5.3"/>
                    <measurement group_id="B3" value="29.7" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Opioid Consumption at 24 Hours Post-op</title>
        <description>Opioid consumption documented in medical recorded will be converted to oral morphine equivalents.</description>
        <time_frame>24 hours after operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption at 24 Hours Post-op</title>
          <description>Opioid consumption documented in medical recorded will be converted to oral morphine equivalents.</description>
          <units>milligrams of oral morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.9" spread="19.8"/>
                    <measurement group_id="O2" value="58.1" spread="34.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Worst Pain Rating Score (NRS-11) at Rest on Postoperative Day 1</title>
        <description>The Numerical Rating Scale (NRS) is an 11-point numeric rating scale, with 0 representing &quot;no pain&quot; and 10 &quot;unbearable pain.&quot; This scale demonstrates reliability and validity and is widely used to assess acute pain after surgery.</description>
        <time_frame>Postoperative Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>Worst Pain Rating Score (NRS-11) at Rest on Postoperative Day 1</title>
          <description>The Numerical Rating Scale (NRS) is an 11-point numeric rating scale, with 0 representing &quot;no pain&quot; and 10 &quot;unbearable pain.&quot; This scale demonstrates reliability and validity and is widely used to assess acute pain after surgery.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="1.9"/>
                    <measurement group_id="O2" value="3.5" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Worst Pain Rating Score (NRS-11) With Movement on Postoperative Day 1</title>
        <description>The Numerical Rating Scale (NRS) is an 11-point numeric rating scale, with 0 representing &quot;no pain&quot; and 10 &quot;unbearable pain.&quot; This scale demonstrates reliability and validity and is widely used to assess acute pain after surgery.</description>
        <time_frame>Postoperative day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>Worst Pain Rating Score (NRS-11) With Movement on Postoperative Day 1</title>
          <description>The Numerical Rating Scale (NRS) is an 11-point numeric rating scale, with 0 representing &quot;no pain&quot; and 10 &quot;unbearable pain.&quot; This scale demonstrates reliability and validity and is widely used to assess acute pain after surgery.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="2.4"/>
                    <measurement group_id="O2" value="6.3" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Opioid Consumption Through 48 Hours</title>
        <description>Total of all opioids consumed converted to oral morphine equivalents.</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Opioid Consumption Through 48 Hours</title>
          <description>Total of all opioids consumed converted to oral morphine equivalents.</description>
          <units>milligrams of oral morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.3" spread="39.8"/>
                    <measurement group_id="O2" value="97.6" spread="56.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Consumption on Postoperative Day 7</title>
        <description>Self-reported (by telephone questionnaire) opioid consumption in oral morphine equivalents on postoperative day 7</description>
        <time_frame>Postoperative day 7</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption on Postoperative Day 7</title>
          <description>Self-reported (by telephone questionnaire) opioid consumption in oral morphine equivalents on postoperative day 7</description>
          <units>milligrams of oral morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" spread="13.7"/>
                    <measurement group_id="O2" value="22.6" spread="24.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Worst Pain Rating Score (NRS-11) on Postoperative Day 7</title>
        <description>The Numerical Rating Scale (NRS) is an 11-point numeric rating scale, with 0 representing &quot;no pain&quot; and 10 &quot;unbearable pain.&quot; This scale demonstrates reliability and validity and is widely used to assess acute pain after surgery.</description>
        <time_frame>Postoperative day 7</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>Worst Pain Rating Score (NRS-11) on Postoperative Day 7</title>
          <description>The Numerical Rating Scale (NRS) is an 11-point numeric rating scale, with 0 representing &quot;no pain&quot; and 10 &quot;unbearable pain.&quot; This scale demonstrates reliability and validity and is widely used to assess acute pain after surgery.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="2.0"/>
                    <measurement group_id="O2" value="5.0" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sleep Quality Measured by Number of Times Awakened by Pain During the First Postoperative Night</title>
        <description>The patient will be questioned by a member of the research team about how many times they were awoken by pain overnight.</description>
        <time_frame>Postoperative day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Quality Measured by Number of Times Awakened by Pain During the First Postoperative Night</title>
          <description>The patient will be questioned by a member of the research team about how many times they were awoken by pain overnight.</description>
          <units>number of times awoken by pain</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction With Pain Control at 24 h</title>
        <description>Patient reported satisfaction with his/her pain control at 24 h on a scale of 0-10 (0=completely dissatisfied, 10=completely satisfied)</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction With Pain Control at 24 h</title>
          <description>Patient reported satisfaction with his/her pain control at 24 h on a scale of 0-10 (0=completely dissatisfied, 10=completely satisfied)</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1" spread="0.9"/>
                    <measurement group_id="O2" value="8.6" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction With Pain Control on Postoperative Day 7</title>
        <description>Patient reported satisfaction with his/her pain control on postoperative day 7 on a scale of 0-10 (0=completely dissatisfied, 10=completely satisfied)</description>
        <time_frame>Postoperative day 7</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction With Pain Control on Postoperative Day 7</title>
          <description>Patient reported satisfaction with his/her pain control on postoperative day 7 on a scale of 0-10 (0=completely dissatisfied, 10=completely satisfied)</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="1.6"/>
                    <measurement group_id="O2" value="8.9" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>20 Meter Walk Test Time Performed on Postoperative Day 1</title>
        <description>This standardized test measures the time it takes for the participant to walk 20 meters at their usual walking pace. The 20-meter walk test is a physical function measure commonly used in clinical research studies and rehabilitation clinics to measure gait speed and monitor changes in patients' physical function over time.</description>
        <time_frame>On postoperative day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
            <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
          </group>
          <group group_id="O2">
            <title>Genicular Nerve Block With Saline</title>
            <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
          </group>
        </group_list>
        <measure>
          <title>20 Meter Walk Test Time Performed on Postoperative Day 1</title>
          <description>This standardized test measures the time it takes for the participant to walk 20 meters at their usual walking pace. The 20-meter walk test is a physical function measure commonly used in clinical research studies and rehabilitation clinics to measure gait speed and monitor changes in patients' physical function over time.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.2" spread="40.8"/>
                    <measurement group_id="O2" value="80.2" spread="43.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Genicular Nerve Block With Bupivacaine and Dexamethasone</title>
          <description>The ultrasound-guided genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.25% bupivacaine 0.67 mg dexamethasone will be administered at each of the 3 genicular nerves.</description>
        </group>
        <group group_id="E2">
          <title>Genicular Nerve Block With Saline</title>
          <description>The ultrasound-guided sham genicular nerve block will be performed at the site of the superior lateral, the superior medial, and the inferior medial genicular nerves. 5 mL of 0.9% normal saline will be administered at each of the 3 genicular nerves.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jeff Gadsden</name_or_title>
      <organization>Duke University</organization>
      <phone>919-681-6437</phone>
      <email>jeff.gadsden@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

